(Q33679365)

English

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Michael J Zelefsky

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xin Pei

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Joanne F Chou

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Michael Schechter

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marisa Kollmeier

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Brett Cox

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yoshiya Yamada

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Anthony Fidaleo

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dahlia Sperling

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Laura Happersett

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zhigang Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

22 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

European Urology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1133-1139

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

21 June 2018

Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

21 June 2018

Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

21 June 2018

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

21 June 2018

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

21 June 2018

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037155

30 October 2018

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21889832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21889832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21889832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21889832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT

1 reference

https://pubmed.ncbi.nlm.nih.gov/21889832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21889832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EURURO.2011.08.029

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33679365&oldid=1949931512"